Skip to main content

Advertisement

SpringerLink
Log in

LncRNA LINC01123 promotes malignancy of ovarian cancer by targeting hsa-miR-516b-5p/VEGFA

  • Research Article
  • Published:
Genes & Genomics Aims and scope Submit manuscript

Abstract

Background

Long non-coding RNAs (lncRNAs) play a critical role in the development of ovarian cancer (OC).

Objective

The study aimed to determine the role of LncRNA LINC01123 in OC bio-progression, which is upregulated in OC tissues during OC progression.

Methods

Bioinformatics methods, GEPIA, and qRT-PCR were used to reveal the level and correlation of LINC01123, hsa-miR-516b-5p, and VEGFA, in OC cell lines. MTT, EdU, TUNEL, and Transwell assays were performed to assess the bioactivity of OC cell. Target sites of LINC01123 and hsa-miR-516b-5p were predicted using Starbase, and the potential linkage points of VEGFA and hsa-miR-516b-5p were predicted using TargetScan. These sites and linkage points were confirmed by double luciferase reporter assay.

Results

LINC01123 was upregulated in OC cell lines and LINC01123 silencing suppressed the proliferation and metastasis of OC cells, but promoted cell apoptosis. hsa-miR-516b-5p was linked to LINC01123 and. VEGFA was downstream of hsa-miR-516b-5p. Importantly, silencing of hsa-miR-516b-5p reversed the inhibitory impact of si-LINC01123. The result of hsa-miR-516b-5p inhibitor + si-LINC01123 co-transfection were rescued by si-VEGFA.

Conclusion

LINC01123 promotes OC development by dampening miR-516b-5p function, and may be a novel target for treating OC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of data and material

The datasets used and/or analysed in the current study are available from the corresponding author upon reasonable request.

References

  • Al Kawas H, Saaid I, Jank P, Westhoff CC, Denkert C, Pross T, Weiler KBS, Karsten MM (2022) How VEGF-A and its splice variants affect breast cancer development—clinical implications. Cell Oncol (Dordr) 45:227–239

    Article  PubMed  CAS  Google Scholar 

  • Bandiera S, Pfeffer S, Baumert TF, Zeisel MB (2015) miR-122—a key factor and therapeutic target in liver disease. J Hepatol 62:448–457

    Article  PubMed  CAS  Google Scholar 

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

    Article  PubMed  Google Scholar 

  • Cao HL, Liu ZJ, Huang PL, Yue YL, Xi JN (2019) lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206. Eur Rev Med Pharmacol Sci 23:1012–1021

    PubMed  Google Scholar 

  • Cao X, Wu W, Wang D, Sun W, Lai S (2022) Glycogen synthase kinase GSK3α promotes tumorigenesis by activating HIF1/VEGFA signaling pathway in NSCLC tumor. Cell Commun Signal 20:32

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Diao P, Song Y, Ge H, Wu Y, Li J, Zhang W, Wang Y, Cheng J (2019) Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma. J Cell Biochem 120:10010–10020

    Article  PubMed  CAS  Google Scholar 

  • Elton TS, Selemon H, Elton SM, Parinandi NL (2013) Regulation of the MIR155 host gene in physiological and pathological processes. Gene 532:1–12

    Article  PubMed  CAS  Google Scholar 

  • Fu Y, Mackowiak B, Feng D, Lu H, Guan Y, Lehner T, Pan H, Wang XW, He Y, Gao B (2023) MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression. Gut. https://doi.org/10.1136/gutjnl-2022-327924

    Article  PubMed  Google Scholar 

  • Guo H, Li J, Fan F, Zhou (2021) LINC00707 regulates miR-382-5p/VEGFA pathway to enhance cervical cancer progression. J Immunol Res 2021:5524632

    Article  PubMed  PubMed Central  Google Scholar 

  • Hua Q, Jin M, Mi B, Xu F, Li T, Zhao L, Liu J, Huang G (2019) LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol 12:91

    Article  PubMed  PubMed Central  Google Scholar 

  • Hulstaert E, Levanon K, Morlion A, Van Aelst S, Christidis AA, Zamar R, Anckaert J, Verniers K, Bahar-Shany K, Sapoznik S et al (2022) RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer. Neoplasia 24:155–164

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kong X, Duan Y, Sang Y, Li Y, Zhang H, Liang Y, Liu Y, Zhang N, Yang Q (2019) LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol 234:9105–9117

    Article  PubMed  CAS  Google Scholar 

  • Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z, Deng X, Chen H, Shen B, Peng C et al (2016) Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene 35:1575–1584

    Article  PubMed  CAS  Google Scholar 

  • Li Q, Zhang J, Zhou J, Yang B, Liu P, Cao L, Jing L, Liu H (2018) lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer. Oncol Lett 15:8363–8370

    PubMed  PubMed Central  Google Scholar 

  • Li F, Niu R, Gao S, Zhao F, Dong Z, Zhang H, Li S (2022a) Pro-angiogenesis role of LINC00662 from esophageal squamous cell carcinoma cells-derived extracellular vehicles. Front Bioeng Biotechnol 10:772514

    Article  PubMed  PubMed Central  Google Scholar 

  • Li X, Wang C, Chen G, Zou W, Deng Y, Zhou F (2022b) EIF4A3-induced circCCNB1 (hsa_circ_0001495) promotes glioma progression by elevating CCND1 through interacting miR-516b-5p and HuR. Metab Brain Dis 37:819–833

    Article  PubMed  CAS  Google Scholar 

  • Lin H, Xu X, Chen K, Fu Z, Wang S, Chen Y, Zhang H, Niu Y, Chen H, Yu H et al (2022) LncRNA CASC15, miR-23b cluster and SMAD3 form a novel positive feedback loop to promote epithelial-mesenchymal transition and metastasis in ovarian cancer. Int J Biol Sci 18:1989–2002

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Liu Z, Ma L, Gu Y, Huang Y, Liang X, Kong L, Sun Y (2022) Long non-coding RNA LINC01123 promotes cell proliferation, migration and invasion via interacting with SRSF7 in colorectal cancer. Pathol Res Pract 232:153843

    Article  PubMed  CAS  Google Scholar 

  • Marth C, Reimer D, Zeimet AG (2017) Front-line therapy of advanced epithelial ovarian cancer: standard treatment. Ann Oncol 28:viii36–viii39

    Article  PubMed  CAS  Google Scholar 

  • Mu HQ, He YH, Wang SB, Yang S, Wang YJ, Nan CJ, Bao YF, Xie QP, Chen YH (2020) MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis. Clin Transl Oncol 22:111–121

    Article  PubMed  CAS  Google Scholar 

  • Shakouri A, Kahroba H, Hamishekar H, Abdolalizadeh J (2022) Nanoencapsulation of Hirudo medicinalis proteins in liposomes as a nanocarrier for inhibiting angiogenesis through targeting VEGFA in the breast cancer cell line (MCF-7). Bioimpacts 12:115–126

    Article  PubMed  CAS  Google Scholar 

  • Shen W, Xie X, Liu M, Wang L (2020) Diagnostic value of lncRNA ROR in differentiating ovarian cancer patients. Clin Lab. https://doi.org/10.7754/Clin.Lab.2019.191035

    Article  PubMed  Google Scholar 

  • Shi Y, Gao S, Zheng Y, Yao M, Ruan F (2019) LncRNA CASC15 functions as an unfavorable predictor of ovarian cancer prognosis and inhibits tumor progression through regulation of miR-221/ARID1A axis. Onco Targets Ther 12:8725–8736

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Shi Y, Fang N, Li Y, Guo Z, Jiang W, He Y, Ma Z, Chen Y (2020) Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis. Cancer Sci 111:2824–2836

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Song H, Li H, Ding X, Li M, Shen H, Li Y, Zhang X, Xing L (2020) Long non-coding RNA FEZF1-AS1 facilitates non-small cell lung cancer progression via the ITGA11/miR-516b-5p axis. Int J Oncol 57:1333–1347

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Tan DSW, Chong FT, Leong HS, Toh SY, Lau DP, Kwang XL, Zhang X, Sundaram GM, Tan GS, Chang MM et al (2017) Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma. Nat Med 23:1167–1175

    Article  PubMed  CAS  Google Scholar 

  • Tian W, Zhang Y, Liu H, Jin H, Sun T (2022) LINC01123 potentially correlates with radioresistance in glioma through the miR-151a/CENPB axis. Neuropathology 42:3–15

    Article  PubMed  CAS  Google Scholar 

  • Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL (2018) Ovarian cancer statistics, 2018. CA Cancer J Clin 68:284–296

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang Y, Li N, Zhao J, Dai C (2022) MiR-193a-5p serves as an inhibitor in ovarian cancer cells through RAB11A. Reprod Toxicol 110:105–112

    Article  PubMed  CAS  Google Scholar 

  • Xiao Z, Liu Y, Zhao J, Li L, Hu L, Lu Q, Zeng Z, Liu X, Huang D, Yang W et al (2020) Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis. Int J Biol Sci 16:2296–2305

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Xiu C, Song R, Jiang J (2021) TUG1 promotes retinoblastoma progression by sponging miR-516b-5p to upregulate H6PD expression. Transl Cancer Res 10:738–747

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Xu Y, Ge Z, Zhang E, Zuo Q, Huang S, Yang N, Wu D, Zhang Y, Chen Y, Xu H et al (2017) The lncRNA TUG1 modulates proliferation in trophoblast cells via epigenetic suppression of RND3. Cell Death Dis 8:e3104

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Xu Y, Ye S, Zhang N, Zheng S, Liu H, Zhou K, Wang L, Cao Y, Sun P, Wang T (2020) The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. Cancer Commun (Lond) 40:484–500

    Article  PubMed  Google Scholar 

  • Yang J, Peng S, Zhang K (2021) LncRNA RP11–499E18.1 inhibits proliferation, migration, and epithelial-mesenchymal transition process of ovarian cancer cells by dissociating PAK2-SOX2 interaction. Front Cell Dev Biol 9:697831

    Article  PubMed  PubMed Central  Google Scholar 

  • Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, Liu F, Pan W, Wang TT, Zhou CC et al (2014) A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25:666–681

    Article  PubMed  CAS  Google Scholar 

  • Zhang ML, Peng P, Wu CX, Gong YM, Zhang SW, Chen WQ, Bao PP (2019) Report of breast cancer incidence and mortality in China registry regions, 2008–2012. Zhonghua Zhong Liu Za Zhi 41:315–320

    PubMed  CAS  Google Scholar 

  • Zhang B, Li Y, Li Y, Zhao H, An R (2022) High expression of microRNA-200a/b indicates potential diagnostic and prognostic biomarkers in epithelial ovarian cancer. Dis Mark 2022:2751696

    Google Scholar 

  • Zhao T, Li C, Wang S, Song X (2019) Green tea (Camellia sinensis): a review of its phytochemistry, pharmacology, and toxicology. Molecules 27:3909

    Article  Google Scholar 

  • Zheng Y, Zhu K, Wang G (2022) miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6. Clin Exp Metastasis 39:603–621

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

This work was supported by the scientific research project of the basic scientific research business expenses of colleges and universities in Heilongjiang Province, 2020 (2020-KYYWF-0019).

Author information

Authors and Affiliations

  1. Department of Gynaecology, The Third Affiliated Hospital of Qiqihar Medical University, No. 27, Taishun Street, Tiefeng, Qiqihar, 161000, Heilongjiang, China

    Bing Dong, Cuiping Li, Xiaomeng Xu, Yan Wang, Yuewen Li & Xingmei Li

Authors
  1. Bing Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cuiping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaomeng Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuewen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xingmei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Research design: BD. Experimental operation: BD, CL, XL. Data statistics and analysis: YW, YL, XL. Draft writing: BD.

Corresponding author

Correspondence to Bing Dong.

Ethics declarations

Conflict of interest

These authors declared no competing interests in this research.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, B., Li, C., Xu, X. et al. LncRNA LINC01123 promotes malignancy of ovarian cancer by targeting hsa-miR-516b-5p/VEGFA. Genes Genom 46, 231–239 (2024). https://doi.org/10.1007/s13258-023-01440-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13258-023-01440-3

Keywords

Search

Navigation